US-based provider of life sciences Azenta, Inc. (Nasdaq: AZTA) announced on Wednesday that it has named John P Marotta as its new president and CEO effective 9 September 2024.

Marotta is to succeed Dr Stephen Schwartz, who is retiring but will continue to serve as an advisor to Azenta. Marotta has two decades of experience heading global companies in life sciences, medical devices and diagnostics. He has served as executive in residence at Patient Square Capital.

Previously, Marotta served as CEO and president of PHC Holdings Corporation (formerly Panasonic Health Care) and also in various senior executive roles in leading life sciences companies, including at Danaher Corporation, Envista Holdings Corporation and Cardinal Health, Inc. He started his career in sales leadership roles for therapeutics and medical device offerings.

Frank E Casal, Azenta board chairman, said, 'Following a rigorous search process, aided by a leading executive search firm, the board and I are thrilled to welcome John as our next president and CEO. We are confident he is the ideal person to lead Azenta into our next chapter. John brings extensive experience leading complex high-growth life sciences businesses around the globe. We look forward to working with him to amplify Azenta's momentum and deliver sustainable value for shareholders.'